The Exercise Capacity and Quality of Life in the Patients With IPAH and Secondary PH
NCT02647060 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26
Last updated 2018-07-11
Summary
Pulmonary hypertension (PH) is a progressive disease with high mortality rate, but due to the development of drugs, the prognosis of the disease has improved. However patients still have poor exercise capacity and decrease of the quality of life. Past studies have shown that idiopathic and secondary PH are different in etiology and prognosis. It is necessary to further understand the difference between exercise capacity and quality of life of these two types of patients.
Conditions
- Hypertension, Pulmonary
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Chien Meng-Yueh, PhD · School and Graduate Institute of Physical Therapy, National Taiwan University
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-13
- Primary Completion
- 2016-04-30
- Completion
- 2016-11-19
Countries
- Taiwan
Study Locations
More Related Trials
-
National Registry and Cohort Study of Pulmonary Vascular Disease
NCT05368467 ·Status: RECRUITING
-
the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension
NCT02061787 ·Status: RECRUITING
-
Effect iNO on Functional Respiratory Imaging in Subjects With WHO Group 3 Pulmonary Hypertension With COPD on Oxygen
NCT03135860 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Spironolactone for Pulmonary Arterial Hypertension
NCT01712620 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Normobaric Hypoxia and Hyperoxia in Patients With Pulmonary Hypertension
NCT03195959 ·Status: COMPLETED
-
The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study
NCT05464095 ·Status: RECRUITING ·Phase: NA
-
3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF
NCT02267655 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Profile of Patients With Pulmonary Hypertension Due to Lung Diseases ( Single Center Experience)
NCT02774928 ·Status: UNKNOWN
-
Metabolic Remodeling in Pulmonary Arterial Hypertension (PAH)
NCT04968210 ·Status: COMPLETED
-
A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
NCT05747508 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Morphine on Dyspnea and 6-Minute Walk Distance in Pulmonary Arterial Hypertension
NCT03401476 ·Status: UNKNOWN ·Phase: PHASE2
-
Transforming Growth Factor Beta Signalling in the Development of Muscle Weakness in Pulmonary Arterial Hypertension
NCT01847716 ·Status: TERMINATED
-
Impact of Rehabilitation Program on PAH Patients Treated With Macitentan.
NCT03045666 ·Status: UNKNOWN ·Phase: NA
-
Utility of Exercise-induced N-terminal (NT) Pro-brain Natriuretic Peptide Levels in Predicting Prognosis in Asymptomatic Aortic Stenosis
NCT00567437 ·Status: TERMINATED ·Phase: NA
-
Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension With/Without Sildenafil
NCT04704440 ·Status: COMPLETED ·Phase: NA
-
Blood Markers Predict Effect of Normobaric Hypoxia at Rest and During Exercise in Patients With Pulmonary Hypertension
NCT04715113 ·Status: COMPLETED ·Phase: NA
-
Hemodynamic Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension
NCT04697875 ·Status: COMPLETED ·Phase: NA
-
Sotatercept on Central Cardiopulmonary Performance and Peripheral Oxygen Transport During Exercise in Pulmonary Arterial Hypertension
NCT06409026 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH
NCT02734953 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Pharmacologic Interaction Between ERAs and PDE-5 Inhibitors on Medication Serum Levels and Clinical Disease Status in Patients With PAH
NCT02484807 ·Status: COMPLETED
-
Assessing the Utility of Submaximal CPET in Treatment Management of PAH
NCT05977933 ·Status: NOT_YET_RECRUITING
-
Responsiveness of Exercise Tests in Pulmonary Arterial Hypertension
NCT01391104 ·Status: COMPLETED ·Phase: NA
-
A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension
NCT05564637 ·Status: COMPLETED ·Phase: PHASE2
-
Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertension
NCT02782052 ·Status: WITHDRAWN ·Phase: PHASE3
-
Integrated Diagnostics Characterization of Right Ventricular Diastolic Flow Dynamics in Pulmonary Arterial Hypertension
NCT01491646 ·Status: COMPLETED